Evidence map›Paper›PMID 34529679›Full record

ArticlePLoS neglected tropical diseases2021

Real-time PCR assay for detection and differentiation of Coccidioides immitis and Coccidioides posadasii from culture and clinical specimens.

Sudha Chaturvedi, Tanya R Victor, Anuradha Marathe, Ketevan Sidamonidze, Kelly L Crucillo, Vishnu Chaturvedi

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Coccidioidomycosis: a growing global concern.The Journal of antimicrobial chemotherapy · 2025
    Review
  4. Review
  5. Review
  6. Review
  7. Risk of Exposure toMicroorganisms · 2023
    Article
  8. Coccidioides Species: A Review of Basic Research: 2022.Journal of fungi (Basel, Switzerland) · 2022
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sudha ChaturvediMycology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, United States of America.ORCID 0000-0003-0906-8426
Tanya R VictorMycology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, United States of America.ORCID 0000-0002-9542-4628
Anuradha MaratheMycology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Ketevan SidamonidzeMycology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Kelly L CrucilloCoccidioidomycosis Serology Laboratory, Department of Medical Microbiology and Immunology, University of California School of Medicine, Davis, California, United States of America.
Vishnu ChaturvediMycology Laboratory, Wadsworth Center, New York State Department of Health, Albany, New York, United States of America.ORCID 0000-0002-3922-9676
New York State Department of Health · US

Funding

ACL HHS U01CK000516NCEZID CDC HHS U01 CK000516
6 · The paper itself

Abstract

Coccidioidomycosis (Valley fever) is a pulmonary and systemic fungal disease with increasing incidence and expanding endemic areas. The differentiation of etiologic agents Coccidioides immitis and C. posadasii remains problematic in the clinical laboratories as conventional PCR and satellite typing schemes are not facile. Therefore, we developed Cy5- and FAM-labeled TaqMan-probes for duplex real-time PCR assay for rapid differentiation of C. immitis and C. posadasii from culture and clinical specimens. The RRA2 gene encoding proline-rich antigen 2, specific for Coccidioides genus, was the source for the first set of primers and probe. Coccidioides immitis contig 2.2 (GenBank: AAEC02000002.1) was used to design the second set of primers and probe. The second primers/probe did not amplify the corresponding C. posadasii DNA, because of an 86-bp deletion in the contig. The assay was highly sensitive with limit of detection of 0.1 pg gDNA/PCR reaction, which was equivalent to approximately ten genome copies of C. immitis or C. posadasii. The assay was highly specific with no cross-reactivity to the wide range of fungal and bacterial pathogens. Retrospective analysis of fungal isolates and primary specimens submitted from 1995 to 2020 confirmed 168 isolates and four primary specimens as C. posadasii and 30 isolates as C. immitis from human coccidioidomycosis cases, while all eight primary samples from two animals (rhesus monkey and rhinoceros) were confirmed as C. posadasii. A preliminary analysis of cerebrospinal fluid (CSF) and pleural fluid samples showed positive correlation between serology tests and real-time PCR for two of the 15 samples. The Coccidioides spp. duplex real-time PCR will allow rapid differentiation of C. immitis and C. posadasii from clinical specimens and further augment the treatment and surveillance of coccidioidomycosis.

Indexed as

Base SequenceCoccidioidesCoccidioidomycosisDNA, FungalFungal ProteinsGene Expression Regulation, FungalHumansReal-Time Polymerase Chain ReactionReproducibility of ResultsRetrospective StudiesSensitivity and SpecificitySpecies SpecificityDNA, FungalFungal Proteins

Identifiers

PMID34529679
PMCPMC8486383
OpenAlexW3152575567

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.